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1. Introduction 
Enlargement of prostate, which affects 50% of men aged 60 and 90% of men by age 80, is 
commonly referred to as benign prostate hyperplasia (BPH) (Russell & Wilson, 1994). BPH is 
a slow, progressive enlargement of the fibromuscular and epithelial structures of the 
prostate gland (Cristoni et al., 2000). Substantial evidence indicates that the androgens 
testosterone (T) and dihydrotestosterone (DHT) contribute to the production of BPH (Lowe 
et al., 2003). The principal serum androgen T is converted by 5alpha-reductase (5aR) to 
DHT. DHT binds to androgen receptor (AR) in the prostate, where it initiates DNA 
synthesis (Marks, 2004). This action, in turn induces protein synthesis and abnormal growth 
of prostate. Current clinical evidence indicates that either the inhibition of 5aR or the 
inhibition of the binding of DHT to AR reverses the symptoms of BPH in human males. 
The effective drugs, finasteride as a 5aR inhibitor and flutamide as a binding inhibitor to AR 
are utiliezed clinically for treatment of BPH. Alternatively functional foods are eclectic 
selection as dietary approaches to prevent BPH in middle-aged men. Natural products are 
frequently used to care BPH in preference to therapeutic agents that can cause severe side-
effects. Plant extracts such as the lipid extracts of saw palmetto berry extract (SPE) have 
also been found to reduce the conversion of testosterone (T) to dihydrotestosterone (DHT) 
by inhibiting 5alpha-reductase (5aR) both in vitro and in vivo (Elliot, 2001). However, few 
products of natural origin besides SPE are believed to be effective against enlargement of 
the prostate. The scientifically-proven food materials are expected to be of benefit for 
prevention of BPH. 
In our preliminary study, the suppressive effects of natural food materials have been found 
in BHT model mice. We introduce here the suppressive effects against BHT of two materials, 
i.e., “banana peel” and “leaf of Houttuynia cordata”. The effects of these materials in the 
androgen-responsive LNCaP human prostate cancer cell line and in effects of BHT model 
mice were examined. These data presented here demonstrate that these materials inhibit the 
growth of the prostate and HCE has anti-androgenic activity. 
2. Experimental 
2.1 Drugs and chemicals 
The chemicals used and their sources were as follows: testosterone propionate and 
dihydrotestosterone from Wako Pure Chemical Industries (Osaka, Japan); flutamide from 
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Sigma–Aldrich Japan (Tokyo); finasteride from LKT Labs. (St. Paul, MN); and pentobarbital 
from Dainippon Sumitomo Pharma (Osaka, Japan). Other chemicals were of analytical grade. 
2.2 Animal experiments 
Male ddY mice (6-8 weeks of age) were purchased from SLC Inc., Shizuoka, Japan. The 
room was maintained at 24±1°C and 50±10% humidity under a 12 h light/dark cycle (lights 
on from 8:00 AM to 8:00 PM), and the animals had free access to water and food. Animal 
studies were conducted according to the 2006 guidelines entitled Notification No. 88 of the 
Ministry of the Environment in Japan and Guidelines for Animal Experimentation of Tokyo 
University of Marine Science and Technology with the approval of the Animal Care and Use 
Committee of Tokyo University of Marine Science and Technology. 
2.3 Growth suppression of mouse prostates and seminal vesicles in testosterone-
induced BPH model mice 
Assay of growth suppression in castrated mouse prostates and seminal vesicles was 
performed based on the OECD protocol. (Yamasaki et al., 2003) The testes of ddY mice were 
removed at 7 weeks of age under anesthesia by intraperitoneal injection of pentobarbital (50 
mg/ml/kg). After 1 d, testosterone propionate (TP) was injected intraperitoneally into the 
mice once daily for 10 d. Enlargement of the reproductive organs in the mice was 
demonstrated dose-dependently due to TP in our preliminary studies as shown in Fig. 1A. 
The growth of these organs is  androgen-dependent (Franck-Lissbrant et al., 1998). 
 
   
Fig. 1. TP-induced regrowth of seminal vesicles (A) and its suppressive effects by flutamide 
(B) in castrated mice 
Testosterone propionate (TP; 2, 10, and 50 mg/kg) was injected i.p. into castrated mice (7-
weeks-old) once daily for 10 days. Flutamide (1, 5, and 25 mg/kg) suspended in 1% ethanol 
and orally administered once daily. The seminal vesicles were removed and weighed and 
compared with castrated mice as a control. Cast: castrated control, Cont: control (TP-
treated), and FL: flutamide. Each value represents the mean ± S.E., n=5. **: p<0.01,***: 
p<0.005 vs control. 
To evaluate the effects on reproductive organs, each of various doses of sample extract was 
suspended in 1% ethanol and orally administered to the BPH model mice once daily. After 
10 d, the mice were weighed, and sacrificed by cervical dislocation. The lengths of the short 
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and long axes of the prostates were then measured with vernier calipers, and the seminal 
vesicles were removed and weighed. In particular, the weights of the seminal vesicles were 
sensitive to androgenic effects in our mice model. Finasteride (FI, 2 mg/kg) and flutamide 
(FL, 10 mg /kg) were used as positive control for the assay system. As shown in Fig. 1B, 
orally administration of flutamide suppressed weight of the seminal vesicles in BPH model 
mice with dose dependent manner (1-25 mg/kg/day) for 10 d. 
2.4 Cell culture and growth studies of human prostate cancer cells 
The LNCaP human prostate cancer cell line is a well-established androgen-dependent cell 
line. (Goldman et al., 2004) AR-positive human prostate cancer LNCaP cells were obtained 
from the Riken BRC Cell Bank (Tsukuba, Japan). The cells were plated onto a 96-well plate 
at a density of 2 × 105 /well and supplemented with 10% charcoal stripped fetal bovine 
serum (CSFBS) obtained from Invitrogen Japan (Tokyo). Twenty-four h later, the cells were 
treated with either vehicle control or androgens (T or DHT) in the presence and the absence 
of each concentration of assessed samples for another 3 d. Sample was dissolved in ethanol 
and added to the cells after further dilution so that the final volume of ethanol was 1% or 
less. After culture, cell proliferation was determined to measure cell viability by 3-[4,5-
dimethyl thiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. (Hamid et al., 2004) 
The cells were treated with 1 mg/ml of MTT for 2 h, and precipitated dye was dissolved 
into dimethylsulfoxide. The absorbance of each well was measured at 570 nm. 
2.5 Statistical analysis 
Data were analyzed statistically by Student’s t-test to determine significant differences in the 
data among the groups. The p values less than 0.05 were considered significant. The values 
were expressed as mean ± S.E. 
3. Banana peel 
 
 
 
 
Fig. 2. Banana peel extract (BPEx) prepared from fresh peel part from organically-cultivated 
bananas showed suppressive effects for enlargement of prostate in BPH model mice 
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3.1 Source material 
The common banana (Musa spp.) is a tropical fruit that grows in the western hemisphere. 
Primarily viewed as a food source, the banana has a fleshy inside portion surrounded by an 
outer typically yellow peel (Fig. 2). The fleshy inside portion, or pulp, is edible when raw, 
and the peel is usually discarded. When ripe, bananas have a deep yellow rind with brown 
spots, and a creamy pulp, which is easily digested. Bananas are rich in carbohydrates and 
contain relatively large amounts of vitamins A, B and C and the minerals potassium and 
phosphorous (Proteggente et al., 2002; Blades et al., 2003). However, banana peel has not 
been studied nutritionally and pharmaceutically as a source of bioactive compounds. In this 
report, we examined the effects of banana peel extract (BPEx) on androgen-induced 
enlargement of accessory reproductive organs in castrated mice. To elucidate the 
mechanisms of action, the effects of BPEx on the androgen-responsive LNCaP human 
prostate cancer cell line were investigated. The data presented here indicate that BPEx 
inhibits growth of the prostate and that BPEx has anti-androgenic activity through 
inhibition of 5aR. 
Fresh banana peel (2.4 kg) of organically-cultivated bananas were cut and extracted with 
methanol at room temperature for 2 days. The extracts were filtered, concentrated under a 
vacuum, and freeze-dried. BPEx (56 g) was stored in a refrigerator before assay.  
3.2 Suppressive effect of benign prostate hyperplasia in mouse 
Our research group has been shown that BPEx treatment (10 d of administration at 0, 50, 
100, and 200 mg/kg per orally) dose-dependently reduced the prostate size and the weights 
of seminal vesicles in the BPH model mice. Then, the effects of BPEx on the growth of mouse 
prostates and seminal vesicles were studied as compared with those of flutamide and 
finasteride in the BPH model mice for 10 d. The short and long axes of the ventral prostates 
and the weights of the seminal vesicles were severely reduced, and when TP (2 mg/kg i.p.) 
was injected, significant growth of prostates and seminal vesicles was induced. BPEx (200 
mg/kg) produced a reduction in prostate weight. Finasteride (2 mg/kg) and flutamide (10 
mg/kg), well-known anti-androgens, showed larger reductions in prostate weight. Similar 
results were observed with regard to seminal vesicle weights. When DHT (6 mg/kg, i.p.) 
was injected in place of T, significant growth of the prostate and seminal vesicles was 
induced. BPEx did not inhibit these effects of DHT (Akamine, 2009). These results indicate 
that orally treatment of BPEx suppress the action of testosterone against enlargement of the 
reproductive organs in vivo. 
3.3 Effects of parts of banana fruit on mouse prostate and seminal vesicles 
Testosterone propionate (TP, 2 mg/kg, i.p.) and sample solution (p.o.) were treated to 
castrated mice once daily for 10 d (Fig. 3). The lengths of the long axes (A) of the prostates of 
mice were measured vernier calipers, and seminal vesicles (B) were removed and weighed. 
Cast, castration only; Cont, control; Pe, banana peel (200 mg/kg); Ed, edible part (200 
mg/kg). Each value represents the mean ± S.E., n=5. *: p<0.05; **: p<0.01 vs. control (TP-
treated without samples). 
Fresh banana fruits separated into two parts, peel and edible part to evaluate suppressive 
effects of the extracts (“Pe” and “Ed”, respectively) on BPH model mice. The inhibitory 
effects of BPEx on the growth of mouse prostates and seminal vesicles were estimated after 
10 d of administration. BPEx dose-dependently reduced the prostate size and the weights of 
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seminal vesicles, and showed almost maximal effect at 200 mg/kg. These results indicate 
that some components in banana peel will be required to suppress prostate enlargement in 
this model. 
 
(A)          (B) 
   
Fig. 3. Effects of extracts of peel (Pe) and edible part (Ed) of banana fruit on TP-induced 
regrowth of prostates and seminal vesicles in castrated mice 
3.4 Inhibitory effects of BPEx on prostate cancer cells 
The effects of BPEx on the proliferation of prostate cancer cells (LNCaP cells) were 
investigated. LNCaP cells show most of the characteristics of human prostatic carcinoma, 
such as dependence on androgens, the presence of ARs, and the production of acid 
phosphatase and prostate-specific antigen. The LNCaP cell line is used as an attractive 
model for in vitro studies of the biology of human prostate cancer. LNCaP cells were 
incubated with different concentrations of BPEx (3.13–100 μg/ml) with and without T or 
DHT for 3 d. In the absence of BPEx, T alone stimulated LNCaP cell number about 20.5 ± 0.5 
x 105 /well, and DHT alone stimulated LNCaP cell numbers to about 30.4 ± 2.1 x 105 /well.  
 
 
Fig. 4. Inhibitory effects of BPEx on the proliferation of LNCaP cells induced by testosterone 
(T) or dihydrotestosterone (DHT) 
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Treatment of LNCaP cells with BPEx in the presence of T resulted in dose-dependent 
inhibition of cell growth. In the presence of T, both finasteride and flutamide inhibited cell 
proliferation. However, in the presence of DHT, while flutamide inhibited cell 
proliferation, finasteride did not. These results indicate that BPEx will suppress on T did 
not affect on DHT in vivo and in vitro experiments. Fig. 4 showed the inhibitory effects of 
anti-androgenic samples at 25 µg/ml on LNCaP cells. Scince BPEx showed similar profile 
with that of FI and not FL, BPEx was estimate to inhibit BPH by its inhibitory activity 
against 5aR. 
Proliferation of prostate cancer cells (LNCaP) were evaluated cell viability (% of control) by 
MTT assay after 3 days incubation with or without samples at 25 µg/ml in the presence of 
testosterone (T: 10 mg/ml) or dihydrotestosterone (DHT: 10 mg/ml). BPEx: banana peel 
extract; FI: finasteride; FI: flutamide. Each data presents as mean±S.E. (n=4).  
4. Leaf of Houttuynia cordata 
 
 
Fig. 5. Houttuynia cordata extract (HCE) prepared from fresh leaf part showed suppressive 
effects for enlargement of prostate in BPH model mice 
4.1 Source material 
Houttuynia cordata Thunb., which is called dokudami in Japanese, is widely distributed in 
eastern Asia, and it has a thin leafstalk and heart-shaped leaf (Fig. 5). It is used in folk 
medicine for diuresis and detoxification. Thus far, it has been reported that H. cordata 
contains many flavonoids (quercitrin, isoquercitrin, rutin, etc.), alkaloids (aristolactam B, 
norcepharadione B, splendidine, etc.), and volatile components of essential oils (methyl-n-
nonyl ketone, lauraldehyde, β-myrcene, etc.) (Meng et al., 2005; Kim et al., 2001; Xu et al., 
2005). The extracts and components exhibit diuretic, anti-obesity (Miyata et al., 2009), 
antioxidative (Kusirisin et al., 2009), antibacterial (Kim et al., 2008), anti-inflammatory (Lu et 
al., 2006), and apoptotic effects (Tang et al., 2009). The effects for benign prostate 
hyperplasia (BPH) of this material have been not investigated. 
The fresh Houttuynia cordata were cut and extracted with 99.5% methanol at room 
temperature for 2 days. The extract were filtered, and concentrated under a vacuum. The 
extract was stored in the refrigerator before assay. 
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We examined the effects of H. cordata extract (HCE) in the androgen-responsive effects in 
BPH model mice and LNCaP human prostate cancer cell line. The data presented here 
demonstrate that HCE inhibits the growth of the prostate with anti-androgenic activity. 
4.2 Suppressive effect of benign prostate hyperplasia in mouse 
Testosterone propionate (TP, 2 mg/kg, i.p.) and sample solution (p.o.) were treated to 
castrated mice once daily for 10 d. The seminal vesicles were removed and weighed. Cast, 
castration only; Cont, TP treated control; HCE: Houttuynia cordata extract (20, 100, and 500 
mg/kg). Each data presents as mean±S.E., n=6, *: p<0.05, **: p<0.01, ***: p<0.005 vs control 
(Cont) as shown in Fig. 6. 
The suppressive effects of HCE on reproductive organs were investigated in testosterone-
induced BPH model mice. The assay to evaluate the effects of HCE on castrated mice 
prostates and seminal vesicles was performed based on the Hershberger assay as a mean of 
rapidly developing in vivo. The testes of ddY mice were removed at 7 weeks of age under 
anesthesia with intraperitoneal injection of pentobarbital (50 mg/ml/kg). After one day of 
orchiectmy, testosterone propionate (TP) 2 mg/kg was injected intraperitoneally (i.p.) into 
the mice once daily for 10 days. HCE was administered once daily. After 10 days, mice were 
weighted and sacrificed by cervical dislocation. The lengths of the long axes of prostate were 
measured by vernier calipers, and seminal vesicles were removed and weighed. 
As shown in Fig. 6, HCE suppress prostates and seminal in a dose-dependent manner at 20, 
100, and 500 mg/kg. 
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Fig. 6. Effects of extracts of HCE on TP-induced regrowth of prostates and seminal vesicles 
in castrated mice 
In the further experiments, the suppressive effects of HCE were compared with flutamide 
(FL, 10 mg/kg/day) and finasteride (FI, 2 mg/kg/day) in BPH model mice. As shown in 
Fig. 7, the size of long-axis length of prostates (A) and the weight of seminal vesicles (B) 
were severely reduced by HCE ingestion, and when T was injected, a significant growth 
of prostates and seminal vesicles was induced. Flutamide and finasteride are well known 
anti-androgen drugs, showed a larger reduction in prostate and seminal vesicle. HCE 
showed suppressive effect on reproductive organs as same as these medicine at these 
experimental conditions. 
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Fig. 7. Evaluation of HCE on T-induced regrowth in castrated mouse prostates and seminal 
vesicles. (A) long-axis length of prostates, (B) weight of seminal vesicles. 
Testosterone propionate (TP, 2 mg/kg, i.p.) and sample solution (p.o.) were treated to 
castrated mice once daily for 10 d. The lengths of the long axes (A) of the prostates of mice 
were measured vernier calipers, and seminal vesicles (B) were removed and weighed. Cast: 
Castration without T-treatment (50 mg/kg, i.p.), Cont: Control, HCE: H. cordata extract (100 
mg/kg), FI : Finasteride 2 mg/kg, FL: Flutamide 10 mg/kg. Each value represents the 
means±S.E., n=5. *:p<0.05, **:p<0.01, ***:p<0.005 vs Control. 
4.3 Inhibitory effects of HCE on LNCaP cells 
The effects of HCE on the proliferation of prostate cancer cells (LNCaP cells) were 
investigated. After incubation, the cell numbers in T-treated and DHT-treated groups were 
defined as 100%. As shown in Fig. 8 finasteride, 5aR inhibitor, showed dose-dependent 
inhibition in T-treated and DHT-treated LNCaP cells. However, its inhibitory effects on 
DHT-treated group are relatively weak. In contrast, flutamide, androgen receptor 
antagonist, showed inhibition both in T alone and DHT alone groups at the similar 
concentrations. On the other hand, the treatment of HCE to LNCaP cells in the presence of T 
and DHT resulted in the concentration-dependent inhibition of cell proliferation at the same 
concentrations as same as case of flutamide treatment. These results indicate that HCE 
suppress enlargement of prostate with a different mechanism with finasteride, 5aR inhibitor. 
Proliferation of prostate cancer cells (LNCaP) were evaluated cell viability (% of control) 
by MTT assay after 3 days incubation with or without samples at 6.25, 25, 100 µg/ml in 
the presence of testosterone (T: 10 mg/ml) or dihydrotestosterone (DHT: 10 mg/ml). 
HCE: Houttuynia cordata extract; FI: finasteride; FI: flutamide. Each data presents as 
mean±S.E. (n=4). 
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Fig. 8. Inhibitory effects of HCE, Flutamide (FL), and Finasteride (FI) on LNCaP cell 
proliferation in the presence of testosterone (T) or dihydrotestosterone (DHT). Each point 
shows the mean of the separated duplicate experiments. 
5. Discussion 
We studied the in vivo potency of BPEx and HCE, as new botanical materials in immature 
castrated mice. We evaluated these biological effects in the androgen-responsive LNCaP 
human prostate cancer cell line and in effects of BHT model mice. 
BPEx inhibited TP-induced growth of prostates and seminal vesicles in castrated mice, 
although it was less potent than finasteride at the same doses. While BPEx inhibited the 
action of TP, it did not inhibit DHT-induced organ growth. In addition, BPEx inhibited 
cell proliferation in the presence of T, but not in the presence of DHT. These results 
suggest that BPEx suppressed the growth of prostates and seminal vesicles by inhibiting 
the conversion of T to DHT, rather than by blocking the binding of androgen and its 
receptor. BPEx may have reduced prostate size and seminal vesicle weight by inhibiting 
5aR. In further study, we found that treatment of LNCaP cells with BPEx inhibited T-
induced cell proliferation (Akamine et al., 2009). The inhibition of this effect of T might 
have be due, at least in part, to inhibition of 5aR or to antagonism of androgen binding to 
the AR (Lazier et al., 2004). Since 25 μg/ml of BPEx inhibited 5aR activity by about 30%, 
we expected to find that this dose would inhibit T action. Similar results have been found 
with finasteride, a well-known inhibitor of 5aR (McConnell et al., 1992; Sudduth & 
Koronkowski, 1993), at doses above 25 μg/ml. Similar results were also found with 
flutamide, an antagonist of androgen binding to the AR (Bergman, & Eriksson, 1996; 
Sundblad et al., 2005). On the other hand, treatment of LNCaP cells with BPEx in the 
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presence of DHT did not result in a dose-dependent inhibition of cell growth. These 
results suggest that inhibition of cell growth in the presence of BPEx was not the result of 
a cell cytotoxic effect, but rather was due to an anti-androgen effect, such as inhibition of 
5aR. According to a previous report describing discrimination between cytotoxic and 
cytostatic effects of integrants on LNCaP cells (Romijn et al., 1988), cytotoxic effects are 
detectable as a decrease in MTT conversion to a level below that of the starting cells. In 
our experiment, growth of androgen-induced LNCaP cells was suppressed without 
decreasing from the starting level in the presence of BPEx during the experimental period. 
Therefore, a cytostatical effect was estimated for suppression of BPEx on LNCaP cell 
growth. However, since no index markers related to apoptotic signaling were measured in 
our experiments, the possibility of a non-cytostatical effect should be considered and 
confirmed in further detailed investigation. There are generally two ways to suppress 
prostate regrowth in animal experiments: by inhibiting 5aR activity, and through the use 
of an androgen receptor antagonist (Imperato-McGinley et al., 1992). An androgen 
antagonist can suppress DHT-induced prostate and seminal vesicle regrowth (Geller et 
al., 1981) Therefore, blocking DHT from binding to androgen receptors in the prostate and 
seminal vesicle is considered to be a possible mechanism of action (other than 5aR 
inhibition) (Nakayama et al., 1997). To examine this possibility, the effects of BPEx on 
prostate growth induced by DHT were investigated. If the suppression of prostate growth 
is caused only by inhibition of 5aR, DHT-induced prostatic regrowth should not be 
suppressed. Ten d after castration, the weights of mouse prostates were markedly 
reduced, and prostate size was restored by i.p. injections of TP or DHT. BPEx had no 
effect on the sizes of the prostate and seminal vesicle of castrated mice that received DHT, 
whereas flutamide, an androgen receptor antagonist, significantly reduced prostate 
weight (Fig. 3). In our study, blood levels of testosterone and samples were not measured, 
but in vivo and in vitro experiments gave mutually correlated results with regard with 
their mechanism of action. These results suggest that BPEx inhibited prostate growth by 
inhibiting 5aR activity rather than by exerting a direct effect on the androgen receptor, 
although the detailed mechanism including bioavailability remains unclear. Recently, 
there is research reports on components of the banana peel: dietary fiber and pectin 
(Happi Emaga et al., 2008), and phytosterol from unripe pulp and peel (Oliveira et al., 
2008) have been reported. In particular, phytosterols are able to be the active principle in 
BPEx, due to their anti-androgen activity based on structural similarity. Investigation to 
elucidate the active components in banana peel is in progress. In this study, we found that 
BPEx can have anti-androgenic activities through in vitro 5aR inhibitory activity and in 
vivo growth suppression of prostates and seminal vesicles from castrated mice.  
In this study, we have shown that HCE inhibited the T-induced growth of prostates and 
seminal vesicles in castrated mice and that HCE inhibited T- and DHT-induced cell 
proliferation in NLCaP cells at the same concentration. The inhibition of this effect of T may 
be due, at least in part, to the inhibition of 5aR or to antagonism of androgen binding to the 
AR. And treatment of LNCaP cells with HCE in the presence of DHT result in the dose-
dependent inhibition of cell growth. These results were seen with flutamide, which is an 
antagonist of androgen binding to the AR. These results suggested that the inhibition of cell 
proliferation in the presence HCE was not the result of a cell cytotoxic effect, but rather was 
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due to an anti-androgen effect, such as inhibition of AR. These results suggest that HCE 
suppressed the growth of prostates and seminal vesicles by blocking the binding to AR, 
rather then by conversion of T to DHT. HCE may have reduced prostate size and seminal 
vesicle weight by blocking the binding of androgen and its receptor. 
There are generally two ways to suppress prostate regrowth in animal experiments: by 
inhibiting 5aR activity and by blocking the binding of androgen and its receptor. An 
androgen antagonist can suppress DHT-induced prostate and seminal vesicle regrowth. 
Therefore, blocking DHT from binding to androgen receptors in the prostate and seminal 
vesicle was considered to be possible mechanism of action (other than 5aR inhibition) of the 
extract of HCE. To examine this possibility, the effects of HCE on LNCaP cells growth 
induced by DHT were investigated. These results suggest that HCE inhibited prostate 
growth by inhibiting androgen receptor rather than by having a direct effect on the 5aR, 
although the detailed mechanism unclear. In this study, we found that HCE may have anti-
androgenic activities through in vitro androgen binding to the AR and in vivo growth 
suppression of prostate and seminal vesicles from castrated mice. Active compounds 
showing anti-androgen activity in HCE are of scientific interest. Since, the clinical 
implications of this activity are currently unknown, further research is needed before is 
needed before HCE can for the treatment of BPH. 
For several years, SPEx has been used as a popular phytotherapeutic agent in the 
treatment of BPH, but its active component and mechanism of action have not been fully 
elucidated (Hill & Kyprianou, 2004). Banana peel is usually considered useless and is 
discarded, but the anti-androgenic activity of BPEx might be useful in the treatment of 
BPH patients. And leaf of H. cordata have been used as folk medicine, however, never 
used for treatment BPH with suppressive effect of androgenic functions. Since the clinical 
implications of this activity are currently unknown, further research is needed before 
BPEx can be used in the treatment of BPH. 
6. Conclusion 
In this chapter, the androgen-responsive effects of the two natural extracts from banana peel 
extract (BPEx) and leaf of H. cordata extract (HCE) were shown in BPH model mice and 
LNCaP human prostate cancer cell line. The data presented here revealed that BPEx was 
estimated to inhibit the growth of the prostate in BPH model mice by its inhibitory activity 
against 5-alpha reductase (5aR). And HCE was estimated to inhibit BPH in mice by its anti-
androgenic activity different from 5aR inhibition. Therefore, these new botanical materials 
can be promising most likely candidates as potential material for preventing benign prostate 
hyperplasia, and it is able to continue to be one of the best preventive medicinal foods to 
keep our good health in the future. 
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